Reply to thread

A ten year study found that hypogonadal men prescribed testosterone undecanoate had fewer major adverse cardiovascular events (MACE) than those who did not receive testosterone. The study also found other cardiovascular markers, such as blood pressure and heart rate imporved on TRT. The results were reported at the annual meating of the American Association of Clinical Endocrinologists. The news report says:


Back
Top